Liver metastases from breast cancer: The relationship between clinical, biochemical and pathological features and survival

Bengmark, 1969, The natural history of primary and secondary malignant tumours of the liver, Cancer, 23, 198, 10.1002/1097-0142(196901)23:1<198::AID-CNCR2820230126>3.0.CO;2-J Jaffe, 1968, Factors influencing survival in patients with untreated hepatic metastases, Surg Gynaecol Obstet, 127, 1 Zinser, 1987, Clinical course of breast cancer patients with liver metastases, J Clin Oncol, 5, 773, 10.1200/JCO.1987.5.5.773 1986, A randomised trial in post-menopausal patients with advanced breast cancer comparing endocrine and cytotoxic therapy given sequentially or in combination, J Clin Oncol, 4, 186, 10.1200/JCO.1986.4.2.186 Bagley, 1973, Clinical pharmacology of cyclophosphamide, Cancer Res, 33, 226 Benjamin, 1974, Adriamycin® chemotherapy, efficacy, safety and pharmologic basis of an intermittent single high dose schedule, Cancer, 33, 19, 10.1002/1097-0142(197401)33:1<19::AID-CNCR2820330107>3.0.CO;2-M Hayward, 1977, Assessment of response to therapy in advanced breast cancer, Eur J Cancer, 13, 89, 10.1016/0014-2964(77)90234-1 Peto, 1977, Design and analysis of clinical trials requiring prolonged observation of each patient. II. Analysis and examples, Br J Cancer, 35, 1, 10.1038/bjc.1977.1 Cox, 1972, Regression models and life tables, J R Stat Soc, 34, 187 Elston, 1980, The relationship of oestradiol receptor (ER) and histological tumour differentiation with prognosis in human primary breast carcinoma, 59 Coleman, 1987, The clinical course of bone metastases from breast cancer, Br J Cancer, 55, 61, 10.1038/bjc.1987.13 Stewart, 1981, Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer, Eur J Cancer, 17, 449, 10.1016/0014-2964(81)90254-1